MILELLA, MICHELE STANISLAW
 Distribuzione geografica
Continente #
NA - Nord America 2.328
EU - Europa 627
AS - Asia 399
AF - Africa 18
SA - Sud America 7
OC - Oceania 2
Totale 3.381
Nazione #
US - Stati Uniti d'America 2.263
IT - Italia 314
SG - Singapore 145
CN - Cina 124
SE - Svezia 121
IN - India 92
CA - Canada 59
DE - Germania 37
RU - Federazione Russa 24
FI - Finlandia 20
ID - Indonesia 20
GB - Regno Unito 19
RO - Romania 19
FR - Francia 13
IE - Irlanda 13
TG - Togo 12
BG - Bulgaria 11
UA - Ucraina 10
BE - Belgio 6
MX - Messico 6
AR - Argentina 5
ES - Italia 5
NL - Olanda 5
TW - Taiwan 5
JP - Giappone 3
AU - Australia 2
BR - Brasile 2
CZ - Repubblica Ceca 2
IR - Iran 2
PL - Polonia 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
UG - Uganda 2
ZA - Sudafrica 2
BJ - Benin 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
Totale 3.381
Città #
Fairfield 405
Ashburn 223
Woodbridge 192
Seattle 183
Houston 161
Wilmington 153
Cambridge 139
Chandler 123
Singapore 113
Santa Clara 70
Ann Arbor 69
Rome 69
San Paolo di Civitate 65
Beijing 55
Princeton 48
Ottawa 44
Lawrence 41
New York 34
Millbury 29
San Diego 28
Dearborn 25
Jakarta 20
Milan 17
Plano 17
Andover 16
Moscow 15
Boston 13
Norwalk 13
Phoenix 13
Lomé 12
Dublin 11
Sofia 11
Helsinki 10
Toronto 9
Bologna 7
Pisa 7
Boardman 6
Fremont 6
Grafing 6
Bristol 5
Brussels 5
Falls Church 5
Federal 5
Frankfurt am Main 5
Genoa 5
Zhongli District 5
Ancona 4
Bühl 4
Collesalvetti 4
Hyderabad 4
Jinan 4
Kunming 4
Los Angeles 4
Mexico City 4
Montréal 4
Ahmedabad 3
Bari 3
Dallas 3
Falconara Marittima 3
Falkenstein 3
Hefei 3
Jacksonville 3
Madrid 3
Mannheim 3
Munich 3
Pune 3
Shanghai 3
Tokyo 3
Bangkok 2
Belgrade 2
Bengaluru 2
Bonate Sotto 2
Bremen 2
Castelfranco di Sotto 2
Catanzaro 2
Cinisello Balsamo 2
Cork 2
Edinburgh 2
Guidonia Montecelio 2
Hamburg 2
Hangzhou 2
Kampala 2
Madison 2
Montechiarugolo 2
Nanjing 2
Orlando 2
Osio Sotto 2
Parma 2
Perugia 2
Riyadh 2
Salerno 2
San Jose 2
San Mateo 2
Sevilla La Nueva 2
Shenyang 2
Southend 2
St. John's 2
Strasbourg 2
Sydney 2
Trento 2
Totale 2.652
Nome #
Impact of the media on the Poison Control Centres: the false outbreak of Loxosceles Rufescens spider bite in Italy 187
Taxanes as primary chemotherapy for early breast cancer. Meta-analysis of randomized trials 112
Role of mTOR signaling in tumor microenvironment. An overview 105
INfluenza vaccine indication during therapy with Immune checkpoint inhibitors: a transversal challenge. the INVIDIa study 96
Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities 94
Renal cancer: new models and approach for personalizing therapy 92
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors. an important role for mutations in minor clones 90
Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells 87
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers 87
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 85
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies 83
P.04.4 PRESENTATION SYMPTOMS AND RISK FACTORS ARE ASSOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH SURVIVAL OF PATIENTS WITH PANCREATIC CANCER 81
HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance 81
Targeting targeted agents. Open issues for clinical trial design 81
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior. 80
Fixed-dose-rate gemcitabine. A viable first-line treatment option for advanced pancreatic and biliary tract cancer 80
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy 78
Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia 77
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models 77
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer 77
Adjuvant treatment for resected renal cell carcinoma. Are all strategies equally negative? Potential implications for trial design with targeted agents 76
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer 75
Probable case of botulism: treating with a grain of salt 75
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment. A meta-analysis 71
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: Meta-analysis of randomized clinical trials 71
Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer 70
Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats 69
Early recurrence risk: Aromatase inhibitors versus tamoxifen 68
Compulsive-like effects of quinpirole on drinking behavior in rats are inhibited by substituting ethanol for water 67
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 66
Emerging pathways and future targets for the molecular therapy of pancreatic cancer 66
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients. Meta-regression analysis of randomized trials 65
Metastatic pancreatic cancer. Is there a light at the end of the tunnel? 65
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer. Meta-analysis of randomized trials 64
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise? 63
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer? Meta-analysis of randomized trials 63
Targeting chemokines and chemokine GPCRs to enhance strong opioid efficacy in neuropathic pain 62
In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat 58
An outbreak of foodborne botulism in Rome 54
null 53
Thyrotoxicosis and anorectic pills a case report 52
Safety and efficacy of cabozantinib in metastatic renal-cell carcinoma: real-world data from an Italian managed access program 52
176. Viper envenomation with ocular neurotocic effects managed without antidote admiistration:a case report 39th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 21-24 May 2019, Naples, Italy 50
The influence of cost manipulation on water contrafreeloading induced by repeated exposure to quinpirole in the rat 48
Heroin and its metabolites: relevance to heroin use disorder 48
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer 29
Transfer of chemicals to a secondary container, from the introduction of new labelling regulation to COVID-19 lockdown: a retrospective analysis of exposure calls to the Poison Control Centre of Rome, Italy, 2017–2020 29
Self-harm by single- and multi-agent medication poisoning in a retrospective analysis of a Poison Control Center database from January 2018 to December 2022 25
Accidental ingestion of nicotine solution for e-cigarettes: a case report 21
E-learning course improves knowledge in tobacco dependence, electronic nicotine delivery systems and heat-not-burn products in Medical School students 19
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations. Differential Effectiveness by Risk Group? 15
Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study 14
Totale 3.553
Categoria #
all - tutte 9.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020771 0 0 0 0 0 150 144 153 134 83 70 37
2020/2021272 62 37 12 38 8 12 3 10 30 41 15 4
2021/2022496 5 26 59 23 53 16 17 54 33 37 97 76
2022/2023559 101 139 27 46 45 43 19 32 56 2 34 15
2023/2024360 21 36 12 25 28 81 10 34 2 48 29 34
2024/2025460 23 144 67 88 88 50 0 0 0 0 0 0
Totale 3.553